1. Exploring Statin Intolerance

2. Incidence/Prevalence of Statin Intolerance

3. Statin AEs

4. High Risk Patients and Statin Intolerance

5. Statins, ASCVD, VA Hospitals

6. Pattern of Statin Use After Discharge for MI

7. Statin Intolerance

8. Key Points About SAMS for Clinicians

9. Who Is at Risk?

10. What Determines Management of SAMS?

11. AEs: Perception vs Evidence Glucose homeostasis -- Clinical Update ESC 2018

12. Benefits of Statins Far Outweigh Risks

13. NLA on Statin Intolerance

14. Spectrum of SAMS Events

15. Ask About Change in Activity

16. Strategies to Address Intolerance

17. Cardiovascular Team-Based Care and the Role of Advanced Practice Providers

18. Statin Pharmacokinetics

19. Statins High/Medium/Low

20. Ethnic Differences in Statin Metabolism

21. Strategies to Address Intolerance

22. Exhaust the Statin Class Before Giving Up

23. NLA Recommendations Consistent With Those Found in the ACC's Tool

24. The Takeaway

25. Keep Trying Benefits Outweighs Risks!

26. Abbreviations

27. Abbreviations (cont)